North Chicago Business
-
Abbott Labs 1Q profit falls 30 percent, revenue climbsApr 20, 2010 11:00 pm - Abbott Laboratories' first-quarter profit met Wall Street expectations on better-than-expected sales of its drug Humira, though the company lowered its profit outlook du...
-
Abbott ordered to turn over e-mails for gov't probeApr 12, 2010 11:00 pm - WASHINGTON - A federal judge has ordered drugmaker Abbott Laboratories to hand over thousands of e-mails in connection with a government investigation into whether the c...
-
Abbott silent on possible Boston Scientific spinoffsApr 08, 2010 11:00 pm - Boston Scientific Corp., the world's second-largest maker of heart devices, is seeking buyers for its Target Therapeutics and neuromodulation units, said a person with k...
-
Abbott sues Lupin to block generic TriLipixMar 31, 2010 11:00 pm - Abbott Laboratories, the maker of the arthritis medicine Humira, sued Lupin Ltd. to prevent the generic-drug maker from selling a copy of the cholesterol drug TriLipix i...
-
Abbott: FDA wants more info on CertriadMar 29, 2010 11:00 pm - AstraZeneca Plc and Abbott Laboratories said U.S. regulators requested additional information on their Certriad heart treatment. The drugmakers, in a statement today, di...
-
Small businesses see pros, cons of new health care lawMar 24, 2010 11:00 pm - Small businesses will either thrive or struggle to survive under the nation's new health care law. Those two sides of the debate are offered by U.S. Rep. Melissa Bean, a...
-
Feds warn of risks in component of Abbott's SimcorMar 18, 2010 11:00 pm - NEW YORK -- The Food and Drug Administration said Friday the highest available dose of Zocor, a component in cholesterol drugs, can cause muscle damage as well as severe...
-
Abbott sues to block generic form of TriLipix as drug questionedMar 14, 2010 11:00 pm - Abbott Laboratories sued to prevent Impax Laboratories Inc. from selling a generic version of the cholesterol drug TriLipix until 2025. Impax said in a statement it is s...
-
Abbott to pay $450 million for Facet BiotechMar 09, 2010 10:00 pm - Abbott Laboratories, maker of the arthritis medicine Humira, succeeded in its bid for Facet Biotech Corp. by offering 54 percent more than Biogen Idec Inc. in its reject...
-
Abbott may be partner for Chi-MedMar 03, 2010 10:00 pm - Hutchison China MediTech Ltd., the pharmaceutical company controlled by Hong Kong billionaire Li Ka-shing, aims to find a partner this year for its experimental treatmen...